Navigation Links
Promising device snags young inventors coveted spot at IShow
Date:6/12/2009

The IShow is for young inventors what "American Idol" is for young performers, and a pair of local researchers has won a coveted spot in the IShow finale in Palm Desert, Calif., this weekend.

If their unique health-monitoring device wins at the American Society of Mechanical Engineers Innovation Showcase, also known as the IShow, on Sunday, University of Houston MBA student Nithin Rajan and Steve Xu, who both work at the Abramson Center for the Future of Health in the Texas Medical Center, could receive up to $10,000 in seed funding from ASME. And that's just the beginning.

All finalists get to pitch their inventions to venture capitalists and "angel investors" who will be in attendance to get their hands on the next big thing.

"The IShow is known for picking the cream of the crop. We know we're facing stiff competition. But, we're passionate about our design, our team and our company moving forward," said Xu. "I can tell you this: We're going to Palm Desert to win."

Though the team's device looks a lot like a standard bathroom scale connected to a bicycle-like handlebar, it is actually a heavy-duty piece of technology meant to offer congestive heart failure patients both peace of mind and significant health-care costs savings.

"Nithan and Steve are developing a technology that is very useful medically, will benefit a large group of patients, and is simple for people to use," said Dr. Cliff Dacso, director of the Abramson Center, the John S. Dunn Sr. Research Chair in General Internal Medicine at The Methodist Hospital, and professor at UH's College of Technology. "Such elegance and purpose of design are rare and tend to be highly sought by investors."

The device, known as the BlueScale, simultaneously records a variety of patient information, including weight, heart rate, blood pressure and cardiac output, in a mere 10 seconds. When combined, those daily measurements offer a good picture of the health o
'/>"/>

Contact: Angela Hopp
ahopp@uh.edu
713-743-8153
University of Houston
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. UC Davis bench-to-bedside research: Promising treatment in clinical trials
2. Therapeutic hypothermia is promising strategy to minimize tissue damage
3. Promising 3-year data: Saving limbs with drug-eluting stents
4. Research uncovers promising target to treat chronic abdominal pain
5. Landscape-scale treatment promising for slowing beetle spread
6. Promising new drug being evaluated as possible treatment option for fragile X syndrome
7. Researchers identify promising gene target for neuroblastoma therapy
8. UCR researchers propose minocycline as a promising drug for patients with Fragile X syndrome
9. Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results
10. Promising new treatment option for women with recurrent ovarian cancer
11. Immunotherapy in high-risk pediatric sarcomas shows promising response
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Promising device snags young inventors coveted spot at IShow
(Date:7/31/2014)... of animal models against the highly infectious and virulent ... disease that kills approximately 30,000 Americans annually. The research ... Immunity . , In the study, the vaccine ... toxins produced by C. difficile , as well ... that mimics the human disease, after only two immunizations. ...
(Date:7/31/2014)... exposure to loud noise alters how the brain ... speech sounds, according to neuroscientists at The University ... published this week in Ear and Hearing ... noise-induced hearing loss affects the brain,s recognition of ... all corners of the population, affecting an estimated ...
(Date:7/31/2014)... step has been made to help better identify and treat ... abnormal narrowing and enlarging of medium sized arteries in the ... other organs causing damage. In a new report appearing in ... , scientists provide evidence that that FMD may not be ... show a connection to abnormalities of bones and joints, as ...
Breaking Biology News(10 mins):C. difficile vaccine proves safe, 100 percent effective in animal models 2UT Dallas study reveals effect of loud noises on brain 2Scientists discover biochemical mechanisms contributing to fibromuscular dysplasia 2
... (CHICAGO - Sept. 30, 2009) U.S. Environmental Protection Agency,s ... of a dioxin exposure study conducted by the University ... the study was conducted well and provided useful, scientifically ... to help EPA fully evaluate human exposure to levels ...
... KINSTON, N.C., Oct. 1 Spatial Integrated Systems, ... integration of solutions incorporating next-generation digital 3D data ... United States patent application has been published for ... 3-dimensional image rendering" under Publication No. US2009/0169095A1. , ...
... University of Warwick and Rothamsted Research have been awarded ... (BBSRC) in partnership with Syngenta, to research the decline ... have fallen by 10-15% over the last 2 years; ... 30% for 2008. Since the declines were first reported ...
Cached Biology News:EPA reviews Univ. of Michigan dioxin study 2Spatial Integrated Systems, Inc. Files Patent Application 2£1 million award to address honeybee decline 2£1 million award to address honeybee decline 3
(Date:7/31/2014)... , July 31, 2014 Research ... "Global Genomics Market 2014-2018" report to their ... Genomics is the study of the genetic material ... be a strong basis for the discovery and development ... human diseases or health conditions. Genomics is supported by ...
(Date:7/31/2014)... Calif. (PRWEB) July 31, 2014 Held ... diagnosed patients with an overview of the disease and ... of drug side effects, as well as updates on ... grateful to Dr. Sandy Srinivas for organizing this educational ... of kidney cancer. “Sandy and her colleagues have put ...
(Date:7/31/2014)... 2014   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade hypothermic storage and ... shipping products for cells and tissues, today announced ... will be released on Thursday, August 7, 2014, and ... live webcast at 4:30 p.m. ET that afternoon. Management ...
(Date:7/30/2014)... , July 30, 2014 Regulus ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 6, 2014, at 5:00 pm Eastern Daylight Time to ...
Breaking Biology Technology:Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2BioLife Solutions to Report Financial Results for Second Quarter 2014 and Provide Business Update on August 7, 2014 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... 2009 Senomyx, Inc. (Nasdaq: SNMX ) will ... 7, 2009 before the opening of the U.S. financial markets. ... a live Internet broadcast that will provide a corporate update ... same day at 11:00 a.m. Eastern Time (8:00 a.m. Pacific ...
... Fla., April 22 OmniComm Systems, Inc. (OTC Bulletin ... the clinical trials market today announced its results of ... the first quarter of 2009 increased approximately 139% to ... 2008. Gross profit margin improved to 79.5% for the ...
... (Nasdaq CM: INSM ), a biopharmaceutical ... call on Wednesday, May 13th at 8:30 AM ET, ... 2009. Insmed intends to issue its quarterly financial ... 13th.To participate in the live conference call, please dial ...
Cached Biology Technology:SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009 2OmniComm Systems Announces 1st Quarter Results of Operations 2OmniComm Systems Announces 1st Quarter Results of Operations 3Insmed to Host First Quarter 2009 Conference Call 2
... Osmometer for both 0.2 and 2.0 mL samples for freezing point determinations. ... Bar code reading capability with optional scanner. RS-232 port. Microprocessor-controlled autocalibration. ... ... ...
MAb to Hu-IFN-Gamma RC2 (CD118), NON-Neutralizing, Clone MMHGR-2 Binds to but does not neutralize human interferon gamma receptor...
Recombinant Rat CINC-2 alpha, CF...
RAT ANTI MOUSE F4/80 ANTIGEN:BIOTIN Immunogen: Thioglycollate stimulated peritoneal macrophages from C57/BL mice...
Biology Products: